Daily as of 3 Nov 16:00 ET
- Price
- above both $159.26 vs 50 $148.48 / 200 $151.97
- Projection
- 🟨Golden cross estimated in 14 to 21 bars
- Test
- No active test
- Last cross
- 💀Death cross 2 Oct 2026 · projected 17 bars out
NVS | Novartis AGNYSEADR golden cross and death cross projections, cross tests and history
$159.26
-$2.26 (-1.40%)
Novartis AG (NVS) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Oct 2026, and the two have been drifting apart, yet a golden cross is projected within 20 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $160.79 vs 50 $149.17 / 200 $116.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 5 Jun 2023 · projected 24 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $159.26 vs 50 $149.81 / 200 $151.45
- Projection
- 🟨Golden cross projected in 6 bars
- Test
- No active test
- Last cross
- 💀Death cross 17 Sep 2026 · projected 13 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Oct 2026 | 💀Death moderate | daily | 17 bars out | Not tested |
| 17 Sep 2026 | 💀Death | 4-hour | 13 bars out | Not tested |
| 13 Jul 2026 | 🟨Golden | 4-hour | 29 bars out | 5 bar cross test |
| 6 May 2026 | 💀Death | 4-hour | 21 bars out | Not tested |
| 4 Apr 2025 | 🟨Golden steep | daily | 28 bars out | 4 bar cross test |
About NVS
ExchangeNYSE
InstrumentADR
Median $ volume, 60 d$262M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
Cap bandmega